Developer docs
API playgroundTry for free, no card

Search company profiles

The Kinetix Group

Full company profile

uuid0006vb5

Namestring
The Kinetix Group
Legal namestring
The Kinetix Group
Company typeenum
Private
Founded yearint
2000
Descriptiontext

The Kinetix Group is a New York-headquartered, privately-held professional services firm founded in 1999 that operates as a subsidiary within Petauri, a purpose-built pharmaceutical-services platform. The company delivers strategic consulting and marketing services to life sciences clients—spanning pharmaceutical, biotech, and medical device companies—alongside health systems, integrated delivery networks (IDNs), patient advocacy groups, and government health agencies. Services span market shaping, commercialization, market access strategy, HEOR, value story development, pull-through and growth maximization, account team training, and HCP/patient engagement.

The firm operates through two formal sub-brands following a recent corporate reorganization: Petauri MAx, a strategic market access marketing agency, and Petauri Kinect, a strategic advisory and marketing agency focused on health system, IDN, and hospital solutions. Its principal proprietary asset is the Networks of Excellence program, a curated network of over 85 health system partners across therapeutic areas including CKD, Behavioral Health, Heart Health, NASH, Oncology, Population Health, and Women's Health, which enables industry-health system collaboration for care pathway adoption and real-world evidence generation.

The business model is B2B professional services delivered via direct enterprise sales to pharma, biotech, and health system buyers, with no publicly disclosed pricing and engagement structures tailored to client needs across the product lifecycle. The company employs 100+ people and is led by co-founders John Strapp (Chairman) and Sarah McNulty (President), with executive leadership including Managing Partner Merissa Oliver, EVP Liz Lucas, and Managing Director JP Strapp. Revenue is generated through project-based and retainer consulting engagements; no technology products, APIs, or AI/ML capabilities are disclosed in available material.

Short descriptiontext

The Kinetix Group is a New York-based life sciences consultancy operating within the Petauri platform, delivering strategic market access, commercialization, and health system advisory services to pharmaceutical, biotech, medical device, and IDN clients through its Petauri MAx and Petauri Kinect sub-brands.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare consulting services, market access strategy, pharmaceutical commercialization, health system advisory, life sciences marketing
NAICS code3 codes
  • Management Consulting Services54161
  • Marketing Consulting Services541613
  • Management, Scientific, and Technical Consulting Services5416
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Pharmaceutical market access consulting
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Strategic Marketing Services
TypeProfessional Services
Description

Professional consulting services including market shaping, commercialization, market access strategy, pull-through and growth maximization, account team training, and HCP/patient engagement services.

thekinetixgroup.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

The Kinetix Group is a professional services firm that helps life sciences companies speed patient access to therapy through strategic market access, commercialization, and health system advisory engagements. It delivers these services through two units—Petauri MAx (market access marketing agency) and Petauri Kinect (health system, IDN, and hospital advisory)—and connects clients to its Networks of Excellence, a community of 85+ health system partners used to advance care delivery and generate real-world evidence.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

The Kinetix Group operates as two complementary units under the Petauri pharmaceutical-services platform: Petauri MAx (a strategic market access marketing agency) and Petauri Kinect (a strategic advisory and marketing agency focused on health system, IDN, and hospital solutions). These units offer broader expertise to support clients with solutions that speed patient access to life-changing care. The company also operates a Networks of Excellence program—a network of over 85 health system partners that facilitates industry-health system collaboration to drive consensus, accelerate care pathway adoption, and generate real-world evidence.

Product and service3 records
1Petauri MAx
CategoryMarket access marketing services
Description

A best-in-class strategic market access marketing agency offering market shaping, commercialization, market access strategy, pull-through and growth maximization, account team training, and HCP and patient engagement services for life sciences companies (pharmaceutical, biotech, medical device).

2Petauri Kinect
CategoryHealth system advisory and marketing services
Description

A strategic advisory and marketing agency focused on health system, IDN, and hospital solutions, providing market access services, health systems strategy, and payer marketing expertise.

3Networks of Excellence
CategoryHealth system partner network program
Description

A growing network of over 85 health system partners that unlocks industry-health system collaboration opportunities to advance care delivery, with focus areas including Behavioral Health, NASH & Liver Disease, Chronic Kidney Disease, Oncology, Women's Health, and Heart Health.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
185+ Health System Partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Growing network of over 85 health system partners across the country working to shape and implement initiatives that close the gap between clinical thought leadership and execution. Network represents nation's leading payers and health systems in areas including CKD, Behavioral Health, Heart Health, NASH, Oncology, Population Health, and Women's Health.

thekinetixgroup.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers5 records
2ZS Associates
TypeDirect peer
Description

ZS Associates is a global consulting firm deeply focused on pharmaceutical market access, sales and marketing, and health plan/provider strategy. It is the closest direct competitor to TKG's Petauri MAx, with similar enterprise pharma client base and overlapping service lines in market access, launch readiness, and pull-through strategy.

TypeBroad incumbent
Description

IQVIA is the largest life sciences services firm, offering consulting, real-world evidence, HEOR, market access, and commercial analytics. It competes with TKG across most service lines but at much greater scale, with integrated technology platforms that TKG cannot match.

TypeBroad incumbent
Description

EVERSANA is a commercial services platform serving life sciences companies with market access, patient services, and commercialization capabilities. Like TKG, it spans pharma services and patient engagement; unlike TKG, it is significantly larger and tech-enabled.

TypeBroad incumbent
Description

Accenture's Life Sciences practice delivers strategy, digital, and operational consulting to global pharma clients. It competes with TKG on commercial strategy and patient services engagements but operates at vastly greater scale and with broader geographic delivery.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Kinetix Group

Pharmaceutical market access consultingthekinetixgroup.com

The Kinetix Group is a New York-based life sciences consultancy operating within the Petauri platform, delivering strategic market access, commercialization, and health system advisory services to pharmaceutical, biotech, medical device, and IDN clients through its Petauri MAx and Petauri Kinect sub-brands.

What The Kinetix Group does

The Kinetix Group is a New York-headquartered, privately-held professional services firm founded in 1999 that operates as a subsidiary within Petauri, a purpose-built pharmaceutical-services platform. The company delivers strategic consulting and marketing services to life sciences clients—spanning pharmaceutical, biotech, and medical device companies—alongside health systems, integrated delivery networks (IDNs), patient advocacy groups, and government health agencies. Services span market shaping, commercialization, market access strategy, HEOR, value story development, pull-through and growth maximization, account team training, and HCP/patient engagement.

The firm operates through two formal sub-brands following a recent corporate reorganization: Petauri MAx, a strategic market access marketing agency, and Petauri Kinect, a strategic advisory and marketing agency focused on health system, IDN, and hospital solutions. Its principal proprietary asset is the Networks of Excellence program, a curated network of over 85 health system partners across therapeutic areas including CKD, Behavioral Health, Heart Health, NASH, Oncology, Population Health, and Women's Health, which enables industry-health system collaboration for care pathway adoption and real-world evidence generation.

The business model is B2B professional services delivered via direct enterprise sales to pharma, biotech, and health system buyers, with no publicly disclosed pricing and engagement structures tailored to client needs across the product lifecycle. The company employs 100+ people and is led by co-founders John Strapp (Chairman) and Sarah McNulty (President), with executive leadership including Managing Partner Merissa Oliver, EVP Liz Lucas, and Managing Director JP Strapp. Revenue is generated through project-based and retainer consulting engagements; no technology products, APIs, or AI/ML capabilities are disclosed in available material.

The Kinetix Group firmographics

Firmographics
Name
The Kinetix Group
Legal name
The Kinetix Group
Website
https://thekinetixgroup.com
Company type
Private
Founded year
2000
Operating status
Operating
Headcount range
51–100 employees
Short description
The Kinetix Group is a New York-based life sciences consultancy operating within the Petauri platform, delivering strategic market access, commercialization, and health system advisory services to pharmaceutical, biotech, medical device, and IDN clients through its Petauri MAx and Petauri Kinect sub-brands.
Ownership category
akta.pro rank

Where The Kinetix Group is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

The Kinetix Group business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Strategic Marketing Services: Professional consulting services including market shaping, commercialization, market access strategy, pull-through and growth maximization, account team training, and HCP/patient engagement services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

The Kinetix Group product offering

Product offering

Core offering

The Kinetix Group is a professional services firm that helps life sciences companies speed patient access to therapy through strategic market access, commercialization, and health system advisory engagements. It delivers these services through two units—Petauri MAx (market access marketing agency) and Petauri Kinect (health system, IDN, and hospital advisory)—and connects clients to its Networks of Excellence, a community of 85+ health system partners used to advance care delivery and generate real-world evidence.

Product overview

The Kinetix Group operates as two complementary units under the Petauri pharmaceutical-services platform: Petauri MAx (a strategic market access marketing agency) and Petauri Kinect (a strategic advisory and marketing agency focused on health system, IDN, and hospital solutions). These units offer broader expertise to support clients with solutions that speed patient access to life-changing care. The company also operates a Networks of Excellence program—a network of over 85 health system partners that facilitates industry-health system collaboration to drive consensus, accelerate care pathway adoption, and generate real-world evidence.

Differentiator

Problem solved

Functional benefit

Products and services

  • Petauri MAx A best-in-class strategic market access marketing agency offering market shaping, commercialization, market access strategy, pull-through and growth maximization, account team training, and HCP and patient engagement services for life sciences companies (pharmaceutical, biotech, medical device).
  • Petauri Kinect A strategic advisory and marketing agency focused on health system, IDN, and hospital solutions, providing market access services, health systems strategy, and payer marketing expertise.
  • Networks of Excellence A growing network of over 85 health system partners that unlocks industry-health system collaboration opportunities to advance care delivery, with focus areas including Behavioral Health, NASH & Liver Disease, Chronic Kidney Disease, Oncology, Women's Health, and Heart Health.

Companies that use The Kinetix Group

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

The Kinetix Group technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

The Kinetix Group partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • 85+ Health System PartnerscoreStrategic or Co-development PartnerGrowing network of over 85 health system partners across the country working to shape and implement initiatives that close the gap between clinical thought leadership and execution. Network represents nation's leading payers and health systems in areas including CKD, Behavioral Health, Heart Health, NASH, Oncology, Population Health, and Women's Health.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

The Kinetix Group competitors and assessment

Company assessment

Peers

Direct peers

  • ZS Associates: ZS Associates is a global consulting firm deeply focused on pharmaceutical market access, sales and marketing, and health plan/provider strategy. It is the closest direct competitor to TKG's Petauri MAx, with similar enterprise pharma client base and overlapping service lines in market access, launch readiness, and pull-through strategy.

Broad incumbents

  • IQVIA: IQVIA is the largest life sciences services firm, offering consulting, real-world evidence, HEOR, market access, and commercial analytics. It competes with TKG across most service lines but at much greater scale, with integrated technology platforms that TKG cannot match.
  • EVERSANA: EVERSANA is a commercial services platform serving life sciences companies with market access, patient services, and commercialization capabilities. Like TKG, it spans pharma services and patient engagement; unlike TKG, it is significantly larger and tech-enabled.
  • Accenture Life Sciences: Accenture's Life Sciences practice delivers strategy, digital, and operational consulting to global pharma clients. It competes with TKG on commercial strategy and patient services engagements but operates at vastly greater scale and with broader geographic delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

The Kinetix Group social profiles

Digital presence

The Kinetix Group financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Kinetix Group leadership team

Management profile

Number of profiles

Profiles7 records

The Kinetix Group funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Kinetix Group M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Kinetix Group

What does The Kinetix Group do?

The Kinetix Group is a professional services firm that helps life sciences companies speed patient access to therapy through strategic market access, commercialization, and health system advisory engagements. It delivers these services through two units—Petauri MAx (market access marketing agency) and Petauri Kinect (health system, IDN, and hospital advisory)—and connects clients to its Networks of Excellence, a community of 85+ health system partners used to advance care delivery and generate real-world evidence.

Is The Kinetix Group a public or private company?

The Kinetix Group is a private company. It is classified as corporate owned and is currently operating.

When was The Kinetix Group founded?

The Kinetix Group was founded in 2000. It employs 51 to 100 people.

Where is The Kinetix Group based?

The Kinetix Group is headquartered in New York, United States, in the North America region.

How does The Kinetix Group make money?

One revenue line is on record: strategic Marketing Services.

Who are The Kinetix Group's main competitors?

McKinsey & Company (Pharma & Medical Products) is listed as a peer. ZS Associates is listed as a direct peer. Broad incumbents are IQVIA, EVERSANA and Accenture Life Sciences.

Does The Kinetix Group have an API?

No public API is recorded for The Kinetix Group.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ThhealthcareDigital Health & HealthTechTechnology Holdings played a crucial role in facilitating a successful merger and acquisition (M&A) process for several design and innovation firms, including Design + Industry, The Kinetix Group, SUAZIO, C-Clear, and Atom Ideas. Their expertise and extensive network resulted in multiple offers and valuable strategic insights, which met the high expectations of these companies. This collaboration will enable these firms to broaden their service offerings and ensure growth in a competitive landscape.PR NewswirePetauri™ Announces Evolution of The Kinetix Group--Powered by Petauri™Petauri announced the restructuring of its subsidiary, The Kinetix Group, into two new specialized business units: Petauri Kinect and Petauri MAx. This strategic move aims to sharpen focus on distinct market segments by separating stakeholder engagement services from payer marketing needs. The reorganization follows rapid growth across the legacy business and evolving marketplace dynamics.PR NewswireThe Kinetix Group Named MM+M Awards Market Access Agency of the Year FinalistThe Kinetix Group has been named a finalist for Market Access Agency of the Year at the 2024 MM+M Awards. This recognition highlights the agency's innovative approaches to market access marketing in areas such as rare diseases and biosimilars, as affirmed by its leadership and parent company Petauri.PR NewswireThe Kinetix Group Releases Insights about Changing Workplace from 35 New HiresThe Kinetix Group (TKG), a healthcare strategic advisory firm, released workplace insights gathered from 35 new hires during company dinners co-hosted by founders John Strapp and Sarah McNulty. Key findings show employees prioritize staff tenure, growth opportunities, community building, and hybrid office formats when evaluating employers, while also valuing customer-facing tasks and early accountability in their careers. The insights, which included employee testimonials praising the company's leadership and culture, are being used by TKG for recruitment and employer branding purposes.PR NewswireThe Kinetix Group Launches Health Equity Blog SeriesThe Kinetix Group (TKG) announced the launch of its new health equity blog series, "Keeping Health Equity Front and Center," on April 15, 2024, to help healthcare decision-makers navigate changing CMS guidance and shifting equity trends. The series aims to address strategies for collecting quality health equity data, including inpatient quality reporting measures, hospital data collection optimization, and organizational compliance demonstration. TKG, which was recently recognized by PM360, stated it hopes to accelerate health equity advancement for hospitals and health systems through sharing insights and best practices.TmcnetThe Kinetix Group Launches Health Equity Blog SeriesThe Kinetix Group launched a health equity blog series titled "Keeping Health Equity Front and Center" to help decision-makers navigate CMS guidance and equity trends. The first blog addresses strategies for collecting quality health equity data, including inpatient quality reporting and hospital data collection. TKG aims to accelerate health equity advancement for hospitals and health systems.YahooThe Kinetix Group Launches Health Equity Blog SeriesThe Kinetix Group launched a health equity blog series titled "Keeping Health Equity Front and Center" to help decision-makers navigate CMS guidance and equity trends. The first blog addresses strategies for collecting quality health equity data, including inpatient quality reporting and hospital data collection. The series aims to accelerate health equity advancement for hospitals and health systems.PR NewswireThe Kinetix Group and Pfizer Health Equity Work Recognized by PM360The Kinetix Group (TKG) and Pfizer's Inflammation and Immunology division received a PM360 Pharma Choice Award for their atopic dermatitis interactive guide designed for varying skin tones. The initiative addressed gaps in equitable patient and provider education resources for skin of color populations. The award, voted by industry professionals, recognizes inclusive work in healthcare marketing and was particularly meaningful for team members involved in the health equity initiative.PR NewswireCKD Leaders Network Publishes New Thought Piece in Journal of Clinical MedicineCKD Leaders Network, a Kinetix Group Network of Excellence dedicated to chronic kidney disease management, announced publication of a new manuscript in the Journal of Clinical Medicine during National Kidney Month. The manuscript highlights universal CKD management challenges across US health systems and calls for urgent implementation strategies to translate research into clinical practice and expand use of new medications for CKD patients. The publication was made possible by an independent grant from Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company.PR NewswireNASHNET Presents Innovative White Paper on Utilizing Biomarkers to Diagnose and Stage NAFLD/NASHNASHNET, a Kinetix Group network dedicated to advancing care pathways for nonalcoholic fatty liver disease (NAFLD) and its severe form NASH, released a white paper on biomarkers for diagnosing and staging these conditions using non-invasive diagnostics. The paper highlights the personal, societal and economic burden of NAFLD, which affects 30% of the global population, and addresses challenges to implementing non-invasive tests in clinical care pathways. The release was timed to coincide with International NASH Day and the International Liver Congress in Vienna, with funding provided by Novo Nordisk.